1. A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. (4th November 2015) Authors: Sharma, Padmanee; Grimm, Marc-Oliver; Galsky, Matthew D; Baron, Ari; Bracarda, Sergio; Siefker-Radtke, Arlene; Lambert, Alexandre; Azrilevich, Alex; Retz, Margitta Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial. (26th October 2022) Authors: Tomita, Yoshihiko; Kobayashi, Ko; Kimura, Go; Oya, Mototsugu; Uemura, Hirotsugu; Nishiyama, Hiroyuki; Galsky, Matthew D; Nasroulah, Federico; Collette, Sandra; Broughton, Edward; Ünsal-Kaçmaz, Keziban; Kamisuki, Yukinori; Bajorin, Dean F Journal: Japanese journal of clinical oncology Issue: Volume 53:Number 1(2023) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Issue 10064 (7th January 2017) Authors: Balar, Arjun V; Galsky, Matthew D; Rosenberg, Jonathan E; Powles, Thomas; Petrylak, Daniel P; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A; van der Heijden, Michiel S; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M; Joseph,... Journal: Lancet Issue: Volume 389:Issue 10064(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Issue 10031 (7th May 2016) Authors: Rosenberg, Jonathan E; Hoffman-Censits, Jean; Powles, Tom; van der Heijden, Michiel S; Balar, Arjun V; Necchi, Andrea; Dawson, Nancy; O'Donnell, Peter H; Balmanoukian, Ani; Loriot, Yohann; Srinivas, Sandy; Retz, Margitta M; Grivas, Petros; Joseph, Richard W; Galsky, Matthew D; Fleming, Mark T; Pe... Journal: Lancet Issue: Volume 387:Issue 10031(2016) Page Start: 1909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. Issue 10236 (16th May 2020) Authors: Galsky, Matthew D; Arija, José Ángel Arranz; Bamias, Aristotelis; Davis, Ian D; De Santis, Maria; Kikuchi, Eiji; Garcia-del-Muro, Xavier; De Giorgi, Ugo; Mencinger, Marina; Izumi, Kouji; Panni, Stefano; Gumus, Mahmut; Özgüroğlu, Mustafa; Kalebasty, Arash Rezazadeh; Park, Se Hoon; Alekseev, Boris;... Journal: Lancet Issue: Volume 395:Issue 10236(2020) Page Start: 1547 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer. (15th December 2022) Authors: Liaw, Bobby C; Tsao, Che-Kai; Seng, Sonia; Jun, Tomi; Gong, Yixuan; Galsky, Matthew D; Oh, William K Journal: Oncologist Issue: Volume 28:Number 4(2023) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Issue 10241 (20th June 2020) Authors: Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; ... Journal: Lancet Issue: Volume 395:Issue 10241(2020) Page Start: 1907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Issue 10241 (20th June 2020) Authors: Kuderer, Nicole M; Choueiri, Toni K; Shah, Dimpy P; Shyr, Yu; Rubinstein, Samuel M; Rivera, Donna R; Shete, Sanjay; Hsu, Chih-Yuan; Desai, Aakash; de Lima Lopes, Gilberto; Grivas, Petros; Painter, Corrie A; Peters, Solange; Thompson, Michael A; Bakouny, Ziad; Batist, Gerald; Bekaii-Saab, Tanios; ... Journal: Lancet Issue: Volume 395:Issue 10241(2020) Page Start: 1907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical trial awareness: Changes over time and sociodemographic disparities. (June 2015) Authors: Leiter, Amanda; Diefenbach, Michael A; Doucette, John; Oh, William K; Galsky, Matthew D Journal: Clinical trials Issue: Volume 12:Number 3(2015) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Current optimal chemotherapy for advanced urothelial cancer. Issue 1 (January 2008) Authors: Sonpavde, Guru; Galsky, Matthew D; Hutson, Thomas E Journal: Expert review of anticancer therapy Issue: Volume 8:Issue 1(2008) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗